Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in San Diego | 208 Studies

Clinical Trials Breast CancerSan Diego

Breast Cancer Clinical Trials in San Diego

Find 208 clinical trials for breast cancer near San Diego, California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in San Diego

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 208 trials

CompletedFour Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerThis randomized phase III trial studies cyclophosphamide and doxorubicin hydrochloride compared with paclitaxel as adjuvant therapy in treating breast cancer in women with 0-3…NCT00041119·Anniston, Alabama and 526 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyThis randomized phase III trial studies radiation therapy to see how well it works with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone…NCT00769379·Anniston, Alabama and 1259 others

CompletedExemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerRATIONALE: The MAP.3 study was designed to test whether hormone therapy using exemestane may prevent breast cancer by blocking the production of estrogen.NCT00083174·Birmingham, Alabama and 75 others

CompletedCombination Chemotherapy in Treating Women With Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003519·Birmingham, Alabama and 133 others

UnknownChemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00408408·Little Rock, Arkansas and 441 others

CompletedA Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerThe primary objective of the study is to assess the progression-free survival (PFS) of veliparib in combination with carboplatin and paclitaxel (C/P) compared to placebo plus C/P…NCT02163694·Gilbert, Arizona and 218 others

CompletedTrial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing SurgeryThis is a Phase 1, open-label, dose escalation study in women with primary, non-recurrent breast cancer undergoing surgery. AVB-620 will be administered prior to surgery.NCT02391194·La Jolla, California and 2 others

Active not recruitingA Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadThis study evaluates the safety of abemaciclib in combination therapies (letrozole, anastrozole, tamoxifen, exemestane, exemestane plus everolimus, trastuzumab, LY3023414 plus…NCT02057133·Rogers, Arkansas and 12 others

Active not recruitingA Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceThe primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive…NCT06492616·Daphne, Alabama and 554 others

CompletedTreatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)The purpose of this study is to evaluate the safety and effectiveness of combined treatment with trastuzumab (Herceptin) and bevacizumab (anti-VEGF antibody) in patients with…NCT00095706·Alhambra, California and 17 others

RecruitingEnhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer SurvivorsThe researchers are doing this study to compare two different types of group therapy and find out whether they are effective approaches for helping breast cancer survivors manage…NCT06728579·San Diego, California and 8 others

Active not recruitingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerThe primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's…NCT05382286·Anchorage, Alaska and 503 others

RecruitingA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerThis is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced breast cancer.NCT03424005·Duarte, California and 54 others

RecruitingMirai-MRI: Validation of AI Models for Breast Cancer RiskThis is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by…NCT07121972·San Diego, California and 3 others

Active not recruitingA Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast cancer.NCT05132582·Phoenix, Arizona and 306 others

RecruitingThe Vanguard Study: Testing a New Way to Screen for CancerThe Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial.NCT06995898·Pleasanton, California and 45 others

CompletedBreast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast CancerRATIONALE: Breast-conserving surgery is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery.NCT01556243·Hot Springs, Arkansas and 349 others

UnknownLetrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00382070·Anniston, Alabama and 805 others

Active not recruitingAxillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionThis phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection.NCT03927027·Little Rock, Arkansas and 95 others

CompletedPaclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerThis randomized phase III trial studies the side effects and how well different chemotherapy regimens with or without bevacizumab work in treating patients with stage IIIC or…NCT00785291·Scottsdale, Arizona and 703 others

PreviousPage 4 of 11Next

Other Conditions in San Diego

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma